Hans Prenen

Center for Oncological Research (CORE), University of Antwerp

Affiliated withUniversity of Antwerp University Hospital Antwerp (UZA)

Research Area

Biography

Hans Prenen has not added Biography.
If you are Hans Prenen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 14	2022

Other Publications

Article	Year
Comparison of multiple protein extraction buffers for GeLC-MS/MS proteomic analysis of liver and colon formalin-fixed, paraffin-embedded tissues. Molecular bioSystems\| PubMed ID: 26676081	2016
RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment. Critical reviews in oncology/hematology\| PubMed ID: 30661662	2019
Tumor-associated macrophages: a short compendium. Cellular and molecular life sciences : CMLS\| PubMed ID: 30747250	2019
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. International journal of molecular sciences\| PubMed ID: 31052546	2019
The potential and controversy of targeting STAT family members in cancer. Seminars in cancer biology\| PubMed ID: 31605750	2020
Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions. Molecular diagnosis & therapy\| PubMed ID: 31838654	2020
SARS-CoV-2 and cancer: Are they really partners in crime? Cancer treatment reviews\| PubMed ID: 32731090	2020
High mortality of cancer patients in times of SARS-CoV-2: Do not generalize! European journal of cancer (Oxford, England : 1990)\| PubMed ID: 32927375	2020
Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies. Critical reviews in oncology/hematology\| PubMed ID: 33310278	2021
The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic. British journal of cancer\| PubMed ID: 33558713	2021
RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies. Frontiers in genetics\| PubMed ID: 33613616	2020
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers\| PubMed ID: 33673405	2021
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 33773276	2021
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation. Science advances\| PubMed ID: 33962944	2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer. Cancer treatment and research communications\| PubMed ID: 34329846	2021
Excellent Response to MEK Inhibition in an Gene Fusion Driven Carcinoma: Case Report and Literature Review. Anticancer research\| PubMed ID: 34969747	2022
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacology & therapeutics\| PubMed ID: 34999181	2022
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia. EMBO reports\| PubMed ID: 35199910	2022
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report. Journal of medical case reports\| PubMed ID: 35831829	2022
Prognostic implications of cellular senescence in resected non-small cell lung cancer. Translational lung cancer research\| PubMed ID: 36090630	2022
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 36341493	2022